Table 3 Combination rates of chemotherapy and these regimens
From: Multi-Institutional Analysis of Early Glottic Cancer from 2000 to 2005
T1a | T1b | T2 | |
|---|---|---|---|
Combination rate (%) | 23† | 22†† | 60 |
Regimen (n) | |||
Low dose CDDP (daily) | 0 | 1 | 6 |
Low dose CDDP/5FU (daily) | 0 | 1 | 2 |
High dose CDDP/5FU | 9 | 5 | 17 |
Carboplatin (daily) | 1 | 0 | 0 |
Carboplatin (weekly) | 4 | 1 | 12 |
CDDP/5FU/DTX | 0 | 0 | 5 |
DTX (Docetaxel) | 1 | 0 | 2 |
UFT (oral antidrug) | 12 | 5 | 6 |
TS-1 (oral antidrug) | 1 | 1 | 0 |